Search results
Results from the WOW.Com Content Network
A 2019 systematic review and meta-analysis found an incidence rate of VTE of 2.3 per 1000 person-years with feminizing hormone therapy in transgender women. [332] For comparison, the rate in the general population has been found to be 1.0–1.8 per 1000 person-years, and the rate in premenopausal women taking birth control pills has been found ...
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
When nonbinary people use hormone therapy, it's typically to masculinize or feminize their bodies in subtle ways to create a more androgynous appearance that is neither male nor female presenting.
Included in the guidelines are sections on purpose and use of the WPATH SOC, the global applicability of the WPATH SOC, the difference between gender nonconformity and gender dysphoria, epidemiology, treatment of children, adolescents and adults, mental health, hormone replacement therapy (masculinizing or feminizing; HRT), reproductive health ...
Gender-affirming hormone therapy is strongly linked to a lower risk of suicide and depression for transgender youths, according to the first large-scale study
Hormone replacement therapy is a crucial part of the transition process for many trans people (Getty) Transgender men and women are increasingly having crucial hormone treatment withdrawn by NHS ...
"Voice therapy" or "voice training" refers to any non-surgical technique used to improve or modify the human voice. [1] [2] Because voice is a social cue to a person's sex and gender, [3] transgender people may frequently undertake voice training or therapy as a part of gender transitioning in order to make their voices sound more typical of their gender, and therefore increase their ...
Target ranges for hormone levels in hormone therapy for transgender women; Source Place Estradiol, total Testosterone, total Refs Endocrine Society: United States: 100–200 pg/mL <50 ng/dL [1] World Professional Association for Transgender Health (WPATH) United States